{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:41:13Z","timestamp":1786995673716,"version":"build-2736575974"},"reference-count":118,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.pharma.2017.04.002","type":"journal-article","created":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T03:15:47Z","timestamp":1494990947000},"page":"323-343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["M\u00e9canismes d\u2019action directs mis en jeu dans les myopathies toxiques"],"prefix":"10.1016","volume":"75","author":[{"given":"A.","family":"Khelfi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Azzouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Abtroun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Reggabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Alamir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pharma.2017.04.002_bib0595","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/157488607779315516","article-title":"Musculoskeletal adverse drug reactions: a review of literature and data from ADR spontaneous reporting databases","volume":"2","author":"Conforti","year":"2007","journal-title":"Curr Drug Saf"},{"issue":"4","key":"10.1016\/j.pharma.2017.04.002_bib0600","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.1365-2710.2001.00360.x","article-title":"Isoprostane 8-epi-PGF2\u03b1 is frequently increased in patients with muscle pain and\/or CK-elevation after HMG-Co-enzyme-A-reductase inhibitor therapy","volume":"26","author":"Sinzinger","year":"2001","journal-title":"J Clin Pharm Ther"},{"issue":"5","key":"10.1016\/j.pharma.2017.04.002_bib0605","first-page":"675","article-title":"7\u00a0alpha- and 7\u00a0beta-hydroperoxycholest-5-en-3\u00a0beta-ol in muscle as indices of oxidative stress: response to ethanol dosage in rats","volume":"24","author":"Adachi","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"issue":"3","key":"10.1016\/j.pharma.2017.04.002_bib0610","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11745-001-0717-5","article-title":"Acute effect of ethanol on 7-hydroperoxycholesterol in muscle and liver","volume":"36","author":"Adachi","year":"2001","journal-title":"Lipids"},{"issue":"6","key":"10.1016\/j.pharma.2017.04.002_bib0615","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/meta.2002.32803","article-title":"Chronic ethanol feeding increases 7-hydroperoxycholesterol and oxysterols in rat skeletal muscle","volume":"51","author":"Fujita","year":"2002","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.pharma.2017.04.002_bib0620","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/oxfordjournals.alcalc.a044914","article-title":"Covalent interactions of acetaldehyde with the actin microfilament system","volume":"24","author":"Xu","year":"1989","journal-title":"Alcohol Alcohol"},{"issue":"1","key":"10.1016\/j.pharma.2017.04.002_bib0625","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1530-0277.1994.tb00898.x","article-title":"Detection of reduced acetaldehyde protein adducts using a unique monoclonal antibody","volume":"18","author":"Klassen","year":"1994","journal-title":"Alcohol Clin Exp Res"},{"issue":"3","key":"10.1016\/j.pharma.2017.04.002_bib0630","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/ajcn\/76.3.668","article-title":"Generation of protein adducts with malondialdehyde and acetaldehyde in muscles with predominantly type I or type II fibers in rats exposed to ethanol and the acetaldehyde dehydrogenase inhibitor cyanamide","volume":"76","author":"Niemela","year":"2002","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.pharma.2017.04.002_bib0635","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.trsl.2014.01.013","article-title":"Translational insight into statin-induced muscle toxicity: from cell culture to clinical studies","volume":"164","author":"Taha","year":"2014","journal-title":"Transl Res"},{"issue":"3","key":"10.1016\/j.pharma.2017.04.002_bib0640","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5551\/jat.12.121","article-title":"Analysis of the global RNA expression profiles of skeletal muscle cells treated with statins","volume":"12","author":"Morikawa","year":"2005","journal-title":"J Atheroscler Thromb"},{"issue":"3","key":"10.1016\/j.pharma.2017.04.002_bib0645","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.taap.2004.04.010","article-title":"Statins induce apoptosis in rat and human myotube cultures by inhibiting protein geranylgeranylation but not ubiquinone","volume":"200","author":"Johnson","year":"2004","journal-title":"Toxicol Appl Pharmacol"},{"issue":"8","key":"10.1016\/j.pharma.2017.04.002_bib0650","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/BF02522982","article-title":"The effects of 3-hydroxy-3-methylglutaryl-CoA reductase inhibition on tissue levels of carnitine and carnitine acyltransferase activity in the rabbit","volume":"31","author":"Bhuiyan","year":"1996","journal-title":"Lipids"},{"issue":"7","key":"10.1016\/j.pharma.2017.04.002_bib0655","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1210\/en.2012-2214","article-title":"Regulation of lipid metabolism by glucocorticoids and 11beta-HSD1\u00a0in skeletal muscle","volume":"154","author":"Morgan","year":"2013","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.pharma.2017.04.002_bib0660","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bbagen.2013.09.010","article-title":"Structural and functional characterization of simvastatin-induced myotoxicity in different skeletal muscles","volume":"1840","author":"Simsek Ozek","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"10.1016\/j.pharma.2017.04.002_bib0665","doi-asserted-by":"crossref","first-page":"E699","DOI":"10.1152\/ajpendo.00006.2015","article-title":"Dysregulation of skeletal muscle protein metabolism by alcohol","volume":"308","author":"Steiner","year":"2015","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.pharma.2017.04.002_bib0670","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1152\/japplphysiol.00180.2014","article-title":"Alcohol impairs skeletal muscle protein synthesis and mTOR signaling in a time-dependent manner following electrically stimulated muscle contraction","volume":"117","author":"Steiner","year":"2014","journal-title":"J Appl Physiol"},{"issue":"3","key":"10.1016\/j.pharma.2017.04.002_bib0675","doi-asserted-by":"crossref","first-page":"E564","DOI":"10.1152\/ajpendo.00383.2010","article-title":"Simvastatin represses protein synthesis in the muscle-derived C2C12\u00a0cell line with a concomitant reduction in eukaryotic initiation factor 2B expression","volume":"300","author":"Tuckow","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.pharma.2017.04.002_bib0680","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.bbamcr.2015.04.010","article-title":"The AKT\/mTOR signaling pathway plays a key role in statin-induced myotoxicity","volume":"1853","author":"Bonifacio","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"10.1016\/j.pharma.2017.04.002_bib0685","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nrrheum.2012.85","article-title":"Implications of glucocorticoid therapy in idiopathic inflammatory myopathies","volume":"8","author":"Hanaoka","year":"2012","journal-title":"Nat Rev Rheumatol"},{"issue":"1\u20132","key":"10.1016\/j.pharma.2017.04.002_bib0690","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.mce.2013.03.003","article-title":"Metabolic functions of glucocorticoid receptor in skeletal muscle","volume":"380","author":"Kuo","year":"2013","journal-title":"Mol Cell Endocrinol"},{"issue":"10","key":"10.1016\/j.pharma.2017.04.002_bib0695","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.biocel.2013.05.036","article-title":"Glucocorticoid-induced skeletal muscle atrophy","volume":"45","author":"Schakman","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"10.1016\/j.pharma.2017.04.002_bib0700","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0092-8674(04)00400-3","article-title":"Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1\u00a0and cause skeletal muscle atrophy","volume":"117","author":"Sandri","year":"2004","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.pharma.2017.04.002_bib0705","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1097-2765(04)00211-4","article-title":"The IGF-1\/PI3K\/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors","volume":"14","author":"Stitt","year":"2004","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.pharma.2017.04.002_bib0710","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1210\/en.2006-0539","article-title":"Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy","volume":"148","author":"Gilson","year":"2007","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.pharma.2017.04.002_bib0715","doi-asserted-by":"crossref","first-page":"e59726","DOI":"10.1371\/journal.pone.0059726","article-title":"PPARbeta\/delta regulates glucocorticoid- and sepsis-induced FOXO1\u00a0activation and muscle wasting","volume":"8","author":"Castillero","year":"2013","journal-title":"Plos One"},{"issue":"1","key":"10.1016\/j.pharma.2017.04.002_bib0720","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1172\/JCI18330","article-title":"Activation of caspase-3\u00a0is an initial step triggering accelerated muscle proteolysis in catabolic conditions","volume":"113","author":"Du","year":"2004","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.pharma.2017.04.002_bib0725","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1097\/01.ASN.0000127211.86206.E1","article-title":"Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3\u00a0kinase","volume":"15","author":"Lee","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"28","key":"10.1016\/j.pharma.2017.04.002_bib0730","doi-asserted-by":"crossref","first-page":"21249","DOI":"10.1074\/jbc.M109.041707","article-title":"Caspase-3\u00a0cleaves specific 19\u00a0S proteasome subunits in skeletal muscle stimulating proteasome activity","volume":"285","author":"Wang","year":"2010","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.pharma.2017.04.002_bib0735","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1083\/jcb.200901052","article-title":"During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation","volume":"185","author":"Cohen","year":"2009","journal-title":"J Cell Biol"},{"issue":"12","key":"10.1016\/j.pharma.2017.04.002_bib0740","first-page":"3940","article-title":"The muscle-specific ubiquitin ligase atrogin-1\/MAFbx mediates statin-induced muscle toxicity","volume":"117","author":"Hanai","year":"2007","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.pharma.2017.04.002_bib0745","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1096\/fj.08-128843","article-title":"Statin-induced muscle damage and atrogin-1\u00a0induction is the result of a geranylgeranylation defect","volume":"23","author":"Cao","year":"2009","journal-title":"Faseb J"},{"issue":"3","key":"10.1016\/j.pharma.2017.04.002_bib0750","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/alcalc\/agv105","article-title":"Acute alcohol-induced decrease in muscle protein synthesis in female mice is REDD-1\u00a0and mTOR-independent","volume":"51","author":"Steiner","year":"2016","journal-title":"Alcohol Alcohol"},{"issue":"1","key":"10.1016\/j.pharma.2017.04.002_bib0755","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/taap.1997.8131","article-title":"Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro","volume":"145","author":"Flint","year":"1997","journal-title":"Toxicol Appl Pharmacol"},{"issue":"11","key":"10.1016\/j.pharma.2017.04.002_bib0760","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1211\/jpp.57.11.0014","article-title":"Statin-induced apoptosis linked with membrane farnesylated Ras small G protein depletion, rather than geranylated Rho protein","volume":"57","author":"Matzno","year":"2005","journal-title":"J Pharm Pharmacol"},{"issue":"18","key":"10.1016\/j.pharma.2017.04.002_bib0765","doi-asserted-by":"crossref","first-page":"15309","DOI":"10.1074\/jbc.M201253200","article-title":"Inhibition of protein geranylgeranylation and RhoA\/RhoA kinase pathway induces apoptosis in human endothelial cells","volume":"277","author":"Li","year":"2002","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.pharma.2017.04.002_bib0770","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1254\/jphs.08238FP","article-title":"Possible mechanisms underlying statin-induced skeletal muscle toxicity in L6\u00a0fibroblasts and in rats","volume":"109","author":"Itagaki","year":"2009","journal-title":"J Pharmacol Sci"},{"issue":"14","key":"10.1016\/j.pharma.2017.04.002_bib0775","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1096\/fj.07-8713com","article-title":"Rab-small GTPases are involved in fluvastatin and pravastatin-induced vacuolation in rat skeletal myofibers","volume":"21","author":"Sakamoto","year":"2007","journal-title":"Faseb J"},{"issue":"5","key":"10.1016\/j.pharma.2017.04.002_bib0780","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1083\/jcb.110.5.1489","article-title":"Isoprenylation is required for the processing of the lamin A precursor","volume":"110","author":"Beck","year":"1990","journal-title":"J Cell Biol"},{"issue":"2","key":"10.1016\/j.pharma.2017.04.002_bib0785","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00925694","article-title":"Studies on the effect of mevinolin (lovastatin) and mevastatin (compactin) on the fusion of L6\u00a0myoblasts","volume":"126","author":"Belo","year":"1993","journal-title":"Mol Cell Biochem"},{"issue":"8740","key":"10.1016\/j.pharma.2017.04.002_bib0790","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/0140-6736(91)91294-5","article-title":"Depletion of muscle mitochondrial-DNA in AIDS patients with zidovudine-induced myopathy","volume":"337","author":"Arnaudo","year":"1991","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.pharma.2017.04.002_bib0795","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJM199004193221602","article-title":"Mitochondrial myopathy caused by long-term zidovudine therapy","volume":"322","author":"Dalakas","year":"1990","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.pharma.2017.04.002_bib0800","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/sj.clpt.6100124","article-title":"Decreased skeletal muscle mitochondrial DNA in patients treated with high-dose simvastatin","volume":"81","author":"Schick","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.pharma.2017.04.002_bib0805","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clpt.2005.03.006","article-title":"High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial","volume":"78","author":"Paiva","year":"2005","journal-title":"Clin Pharmacol Ther"},{"issue":"36","key":"10.1016\/j.pharma.2017.04.002_bib0810","doi-asserted-by":"crossref","first-page":"28110","DOI":"10.1074\/jbc.M001280200","article-title":"Inhibition of selenoprotein synthesis by selenocysteine tRNA[Ser]Sec lacking isopentenyladenosine","volume":"275","author":"Warner","year":"2000","journal-title":"J Biol Chem"},{"issue":"Suppl. 2","key":"10.1016\/j.pharma.2017.04.002_bib0815","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.2337\/dc09-S302","article-title":"Skeletal muscle insulin resistance is the primary defect in type 2\u00a0diabetes","volume":"32","author":"DeFronzo","year":"2009","journal-title":"Diabetes Care"},{"issue":"Pt 3","key":"10.1016\/j.pharma.2017.04.002_bib0820","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1042\/bj3210707","article-title":"Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle","volume":"321","author":"Dimitriadis","year":"1997","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.pharma.2017.04.002_bib0825","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0026-0495(98)90184-6","article-title":"Dexamethasone inhibits insulin-stimulated recruitment of GLUT4\u00a0to the cell surface in rat skeletal muscle","volume":"47","author":"Weinstein","year":"1998","journal-title":"Metabolism"},{"issue":"4\u00a0Pt 1","key":"10.1016\/j.pharma.2017.04.002_bib0830","article-title":"Effect of hypercorticism on regulation of skeletal muscle glycogen metabolism by epinephrine","volume":"262","author":"Coderre","year":"1992","journal-title":"Am J Physiol"},{"issue":"11","key":"10.1016\/j.pharma.2017.04.002_bib0835","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.2337\/db09-0525","article-title":"11beta-hydroxysteroid dehydrogenase type 1\u00a0regulates glucocorticoid-induced insulin resistance in skeletal muscle","volume":"58","author":"Morgan","year":"2009","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.pharma.2017.04.002_bib0840","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1210\/jc.2007-1399","article-title":"Glucocorticoid modulation of insulin signaling in human subcutaneous adipose tissue","volume":"92","author":"Gathercole","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.pharma.2017.04.002_bib0845","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.abb.2008.02.034","article-title":"Insulin action and signalling in fat and muscle from dexamethasone-treated rats","volume":"474","author":"Bur\u00e9n","year":"2008","journal-title":"Arch Biochem Biophys"},{"issue":"10","key":"10.1016\/j.pharma.2017.04.002_bib0850","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1007\/s00125-005-1886-0","article-title":"Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3\u00a0inhibitor","volume":"48","author":"Ruzzin","year":"2005","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.pharma.2017.04.002_bib0855","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1210\/en.2007-1214","article-title":"Effect of dexamethasone on glucose tolerance and fat metabolism in a diet-induced obesity mouse model","volume":"149","author":"Gounarides","year":"2008","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.pharma.2017.04.002_bib0860","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2007.01.002","article-title":"Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance","volume":"5","author":"Holland","year":"2007","journal-title":"Cell Metab"},{"issue":"4","key":"10.1016\/j.pharma.2017.04.002_bib0865","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2337\/diabetes.53.4.899","article-title":"Protein kinase B-alpha inhibits human pyruvate dehydrogenase kinase-4\u00a0gene induction by dexamethasone through inactivation of FOXO transcription factors","volume":"53","author":"Kwon","year":"2004","journal-title":"Diabetes"},{"issue":"1\u20132","key":"10.1016\/j.pharma.2017.04.002_bib0870","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.mce.2009.08.011","article-title":"Regulation of pyruvate dehydrogenase kinase isoform 4 (PDK4) gene expression by glucocorticoids and insulin","volume":"315","author":"Connaughton","year":"2010","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"10.1016\/j.pharma.2017.04.002_bib0875","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/dmrr.944","article-title":"Glucocorticoid-mediated effects on metabolism are reversed by targeting 11\u00a0beta hydroxysteroid dehydrogenase type 1\u00a0in human skeletal muscle","volume":"25","author":"Salehzadeh","year":"2009","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"10.1016\/j.pharma.2017.04.002_bib0880","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijpharm.2006.02.043","article-title":"Inhibitory effects of statins on human monocarboxylate transporter 4","volume":"317","author":"Kobayashi","year":"2006","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"10.1016\/j.pharma.2017.04.002_bib0885","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijpharm.2007.04.010","article-title":"Preventive effects of bicarbonate on cerivastatin-induced apoptosis","volume":"341","author":"Kobayashi","year":"2007","journal-title":"Int J Pharm"},{"issue":"5","key":"10.1016\/j.pharma.2017.04.002_bib0890","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1248\/yakushi.132.609","article-title":"Effects of acidification and alkalinization agent on statins-induced muscle toxicity","volume":"132","author":"Kobayashi","year":"2012","journal-title":"Yakugaku Zasshi"},{"issue":"11","key":"10.1016\/j.pharma.2017.04.002_bib0895","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.1167\/iovs.10-5278","article-title":"Induction of lysosomal dilatation, arrested autophagy, and cell death by chloroquine in cultured ARPE-19\u00a0cells","volume":"51","author":"Yoon","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"18","key":"10.1016\/j.pharma.2017.04.002_bib0900","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1007\/s00018-008-8113-3","article-title":"Cellular pathology induced by snake venom phospholipase A(2) myotoxins and neurotoxins: common aspects of their mechanisms of action","volume":"65","author":"Montecucco","year":"2008","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"10.1016\/j.pharma.2017.04.002_bib0905","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1124\/jpet.105.086462","article-title":"Delineation of myotoxicity induced by 3-hydroxy-3-methylglutaryl CoA reductase inhibitors in human skeletal muscle cells","volume":"314","author":"Sacher","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.pharma.2017.04.002_bib0910","doi-asserted-by":"crossref","first-page":"C810","DOI":"10.1152\/ajpcell.1996.271.3.C810","article-title":"H2O2\u00a0modulates twitch tension and increases Po of Ca2+ release channel in frog skeletal muscle","volume":"271","author":"Oba","year":"1996","journal-title":"Am J Physiol-Cell Physiol"},{"issue":"2","key":"10.1016\/j.pharma.2017.04.002_bib0915","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1469-7793.1998.565bn.x","article-title":"Effect of hydrogen peroxide and dithiothreitol on contractile function of single skeletal muscle fibres from the mouse","volume":"509","author":"Andrade","year":"1998","journal-title":"J Physiol (Lond)"},{"issue":"6","key":"10.1016\/j.pharma.2017.04.002_bib0920","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","article-title":"Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies","volume":"52","author":"Octavia","year":"2012","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"10.1016\/j.pharma.2017.04.002_bib0925","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF02592449","article-title":"Exogenous CoQ(10) preserves plasma ubiquinone levels in patients treated with 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors","volume":"24","author":"Bargossi","year":"1994","journal-title":"Int J Clin Lab Res"},{"issue":"11","key":"10.1016\/j.pharma.2017.04.002_bib0930","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1136\/jcp.46.11.1055","article-title":"Plasma coenzyme-Q (ubiquinone) concentrations in patients treated with simvastatin","volume":"46","author":"Watts","year":"1993","journal-title":"J Clin Pathol"},{"issue":"22","key":"10.1016\/j.pharma.2017.04.002_bib0935","doi-asserted-by":"crossref","first-page":"8928","DOI":"10.1073\/pnas.87.22.8928","article-title":"Lovastatin decreases coenzyme Q levels in rats","volume":"87","author":"Willis","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"10.1016\/j.pharma.2017.04.002_bib0940","doi-asserted-by":"crossref","first-page":"8931","DOI":"10.1073\/pnas.87.22.8931","article-title":"Lovastatin decreases coenzyme Q levels in humans","volume":"87","author":"Folkers","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.pharma.2017.04.002_bib0945","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0011-393X(98)85064-9","article-title":"A comparison of the effects of lovastatin and pravastatin on ubiquinone tissue levels in rats","volume":"59","author":"Rousseau","year":"1998","journal-title":"Curr Ther Res"},{"issue":"4","key":"10.1016\/j.pharma.2017.04.002_bib0950","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF00194398","article-title":"Serum ubiquinone concentrations after short- and long-term treatment with HMG-CoA reductase inhibitors","volume":"46","author":"Laaksonen","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pharma.2017.04.002_bib0955","first-page":"47","article-title":"Muscular effects of statins in the elderly female: a review","volume":"8","author":"Bhardwaj","year":"2013","journal-title":"Clin Interv Aging"},{"issue":"14","key":"10.1016\/j.pharma.2017.04.002_bib0960","doi-asserted-by":"crossref","first-page":"12221","DOI":"10.1074\/jbc.M108938200","article-title":"Bupivacaine myotoxicity is mediated by mitochondria","volume":"277","author":"Irwin","year":"2002","journal-title":"J Biol Chem"},{"issue":"1\u20133","key":"10.1016\/j.pharma.2017.04.002_bib0965","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.tox.2005.11.007","article-title":"Statins induce calcium-dependent mitochondrial permeability transition","volume":"219","author":"Velho","year":"2006","journal-title":"Toxicology"},{"issue":"6","key":"10.1016\/j.pharma.2017.04.002_bib0970","doi-asserted-by":"crossref","first-page":"E1273","DOI":"10.1152\/ajpendo.00019.2003","article-title":"Acute and chronic effects of alcohol exposure on skeletal muscle c-myc, p53, and Bcl-2\u00a0mRNA expression","volume":"285","author":"Nakahara","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"19","key":"10.1016\/j.pharma.2017.04.002_bib0975","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1016\/j.lfs.2003.11.001","article-title":"MAP kinase signaling in diverse effects of ethanol","volume":"74","author":"Aroor","year":"2004","journal-title":"Life Sci"},{"issue":"6","key":"10.1016\/j.pharma.2017.04.002_bib0980","doi-asserted-by":"crossref","first-page":"E916","DOI":"10.1152\/ajpendo.00554.2003","article-title":"IGF-I\/IGFBP-3\u00a0ameliorates alterations in protein synthesis, eIF4E availability, and myostatin in alcohol-fed rats","volume":"286","author":"Lang","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.pharma.2017.04.002_bib0985","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/mus.20036","article-title":"Oxidative stress-associated mitochondrial dysfunction in corticosteroid-treated muscle cells","volume":"30","author":"Oshima","year":"2004","journal-title":"Muscle Nerve"},{"issue":"8","key":"10.1016\/j.pharma.2017.04.002_bib0990","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1210\/endo.141.8.7621","article-title":"Dexamethasone inhibits insulin-like growth factor signaling and potentiates myoblast apoptosis","volume":"141","author":"Singleton","year":"2000","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.pharma.2017.04.002_bib0995","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/mus.20139","article-title":"Effects of exercise and steroid on skeletal muscle apoptosis in the mdx mouse","volume":"30","author":"Lim","year":"2004","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.pharma.2017.04.002_bib1000","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1365-2990.2001.00344.x","article-title":"Fas mediates apoptosis in steroid-induced myopathy of rats","volume":"27","author":"Lee","year":"2001","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"7","key":"10.1016\/j.pharma.2017.04.002_bib1005","doi-asserted-by":"crossref","first-page":"1806S","DOI":"10.1093\/jn\/135.7.1806S","article-title":"Apoptosis of skeletal muscle on steroid-induced myopathy in rats","volume":"135","author":"Lee","year":"2005","journal-title":"J Nutr"},{"key":"10.1016\/j.pharma.2017.04.002_bib1010","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1196\/annals.1299.035","article-title":"A novel antioxidant-inhibited dexamethasone-mediated and caspase-3-independent muscle cell death","volume":"1010","author":"Orzechowski","year":"2003","journal-title":"Ann NY Acad Sci"},{"issue":"4","key":"10.1016\/j.pharma.2017.04.002_bib1015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1051\/medsci\/2009254323","article-title":"L\u2019autophagie, d\u00e9grader plus pour vivre plus\u2026 mais attention\u00a0!","volume":"25","author":"Codogno","year":"2009","journal-title":"Med Sci (Paris)"},{"issue":"Suppl. 1","key":"10.1016\/j.pharma.2017.04.002_bib1020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0761-8425(08)74070-1","article-title":"Autophagie\u00a0: autocannibalisme ou autod\u00e9fense\u00a0?","volume":"25","author":"Bonniaud","year":"2008","journal-title":"Rev Mal Respir"},{"issue":"3","key":"10.1016\/j.pharma.2017.04.002_bib1025","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1051\/jbio:2005024","article-title":"Autophagy in cell survival and death","volume":"199","author":"Codogno","year":"2005","journal-title":"J Soc Biol"},{"issue":"3","key":"10.1016\/j.pharma.2017.04.002_bib1030","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/35056522","article-title":"Molecular dissection of autophagy: two ubiquitin-like systems","volume":"2","author":"Ohsumi","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"10.1016\/j.pharma.2017.04.002_bib1035","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00401-009-0488-1","article-title":"Amyloid-beta accumulation caused by chloroquine injections precedes ER stress and autophagosome formation in rat skeletal muscle","volume":"117","author":"Ikezoe","year":"2009","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1016\/j.pharma.2017.04.002_bib1040","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0002-9440(10)65682-9","article-title":"Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy","volume":"153","author":"Fukuchi","year":"1998","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.pharma.2017.04.002_bib1045","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.2353\/ajpath.2006.051232","article-title":"Genetically augmenting Abeta42\u00a0levels in skeletal muscle exacerbates inclusion body myositis-like pathology and motor deficits in transgenic mice","volume":"168","author":"Kitazawa","year":"2006","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.pharma.2017.04.002_bib1050","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/mus.20288","article-title":"Skeletal muscle expression of clathrin and mannose 6-phosphate receptor in experimental chloroquine-induced myopathy","volume":"31","author":"Masuda","year":"2005","journal-title":"Muscle Nerve"},{"issue":"25","key":"10.1016\/j.pharma.2017.04.002_bib1055","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1056\/NEJM198706183162502","article-title":"Colchicine myopathy and neuropathy","volume":"316","author":"Kuncl","year":"1987","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.pharma.2017.04.002_bib1060","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000103376","article-title":"Expression of autophagy-associated genes in skeletal muscle: an experimental model of chloroquine-induced myopathy","volume":"74","author":"Kimura","year":"2007","journal-title":"Pathobiology"},{"issue":"5","key":"10.1016\/j.pharma.2017.04.002_bib1065","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/oxfordjournals.jbchem.a003147","article-title":"The first molecular evidence that autophagy relates rimmed vacuole formation in chloroquine myopathy","volume":"131","author":"Suzuki","year":"2002","journal-title":"J Biochem"},{"issue":"4","key":"10.1016\/j.pharma.2017.04.002_bib1070","doi-asserted-by":"crossref","first-page":"e36221","DOI":"10.1371\/journal.pone.0036221","article-title":"Clinical utility of lc3\u00a0and p62\u00a0immunohistochemistry in diagnosis of drug-induced autophagic vacuolar myopathies: a case-control study","volume":"7","author":"Lee","year":"2012","journal-title":"Plos One"},{"issue":"1\u20132","key":"10.1016\/j.pharma.2017.04.002_bib1075","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3940(95)12205-2","article-title":"Amyloid beta protein in rat soleus muscle in chloroquine-induced myopathy using end-specific antibodies for A beta 40\u00a0and A beta 42: immunohistochemical evidence for amyloid beta protein","volume":"202","author":"Tsuzuki","year":"1995","journal-title":"Neurosci Lett"},{"issue":"2","key":"10.1016\/j.pharma.2017.04.002_bib1080","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/0006-8993(95)00917-F","article-title":"Co-localization of amyloid-associated proteins with amyloid beta in rat soleus muscle in chloroquine-induced myopathy: a possible model for amyloid beta formation in Alzheimer's disease","volume":"699","author":"Tsuzuki","year":"1995","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.pharma.2017.04.002_bib1085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2613.1997.9950333.x","article-title":"Snake coiled fibres in rat soleus muscle in chloroquine induced myopathy share immunohistochemical characteristics with amyloid depositions in Alzheimer's disease brain tissue","volume":"78","author":"Tsuzuki","year":"1997","journal-title":"Int J Exp Pathol"},{"issue":"2","key":"10.1016\/j.pharma.2017.04.002_bib1090","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0304-3940(94)90785-4","article-title":"Immunohistochemical evidence for amyloid beta in rat soleus muscle in chloroquine-induced myopathy","volume":"182","author":"Tsuzuki","year":"1994","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.pharma.2017.04.002_bib1095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-0102(98)00020-0","article-title":"Chloroquine myopathy suggests that tau is degraded in lysosomes: implication for the formation of paired helical filaments in Alzheimer's disease","volume":"31","author":"Oyama","year":"1998","journal-title":"Neurosci Res"},{"issue":"4","key":"10.1016\/j.pharma.2017.04.002_bib1100","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000116412","article-title":"Experimental chloroquine myopathy: morphological and biochemical studies","volume":"29","author":"Kumamoto","year":"1989","journal-title":"Eur Neurol"},{"issue":"5","key":"10.1016\/j.pharma.2017.04.002_bib1105","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/(SICI)1097-4598(199805)21:5<665::AID-MUS19>3.0.CO;2-U","article-title":"Effect of chloroquine-induced myopathy on rat soleus muscle sarcoplasm and expression of clathrin","volume":"21","author":"Kumamoto","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.pharma.2017.04.002_bib1110","first-page":"127","volume":"13","author":"Ohkuma","year":"1981","journal-title":"Intralysosomal pH and its function with special reference to the effect of basic substances. Cell (Tokyo)"},{"issue":"2","key":"10.1016\/j.pharma.2017.04.002_bib1115","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0014-4886(81)90090-X","article-title":"Inhibition of lysosomal function in red and white skeletal muscles by chloroquine","volume":"71","author":"Stauber","year":"1981","journal-title":"Exp Neurol"},{"issue":"18","key":"10.1016\/j.pharma.2017.04.002_bib1120","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/0006-2952(74)90174-9","article-title":"Lysosomotropic agents","volume":"23","author":"Deduve","year":"1974","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1016\/j.pharma.2017.04.002_bib1125","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0303-8467(03)00023-4","article-title":"protein in chloroquine-induced axonal polyneuropathy and myopathy","volume":"105","author":"Finsterer","year":"2003","journal-title":"Clin Neurol Neurosurg"},{"issue":"8","key":"10.1016\/j.pharma.2017.04.002_bib1130","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/mus.880160803","article-title":"Effect of denervation on overdevelopment of chloroquine-induced autophagic vacuoles in skeletal muscles","volume":"16","author":"Kumamoto","year":"1993","journal-title":"Muscle Nerve"},{"issue":"11","key":"10.1016\/j.pharma.2017.04.002_bib1135","doi-asserted-by":"crossref","first-page":"e1001708","DOI":"10.1371\/journal.pbio.1001708","article-title":"Role of autophagy in glycogen breakdown and its relevance to chloroquine myopathy","volume":"11","author":"Zirin","year":"2013","journal-title":"PLoS Biol"},{"issue":"2","key":"10.1016\/j.pharma.2017.04.002_bib1140","doi-asserted-by":"crossref","first-page":"e1005006","DOI":"10.1371\/journal.pgen.1005006","article-title":"Regulators of autophagosome formation in Drosophila muscles","volume":"11","author":"Zirin","year":"2015","journal-title":"Plos Genet"},{"key":"10.1016\/j.pharma.2017.04.002_bib1145","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s40478-016-0384-6","article-title":"Activation of the Keap1\/Nrf2\u00a0stress response pathway in autophagic vacuolar myopathies","volume":"4","author":"Duleh","year":"2016","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"10.1016\/j.pharma.2017.04.002_bib1150","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/mus.21621","article-title":"Branched-chain amino acids protect against dexamethasone-induced soleus muscle atrophy in rats","volume":"41","author":"Yamamoto","year":"2010","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.pharma.2017.04.002_bib1155","doi-asserted-by":"crossref","first-page":"677","DOI":"10.4161\/auto.27918","article-title":"Alcohol-induced autophagy contributes to loss in skeletal muscle mass","volume":"10","author":"Thapaliya","year":"2014","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.pharma.2017.04.002_bib1160","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.canrad.2015.06.021","article-title":"Radiation-induced undifferentiated pleomorphic sarcoma after radiation therapy for a desmoid tumour","volume":"20","author":"Di Marco","year":"2016","journal-title":"Cancer Radiother"},{"issue":"3","key":"10.1016\/j.pharma.2017.04.002_bib1165","first-page":"187","article-title":"Myopathies toxiques\u00a0: vue d\u2019ensemble","volume":"28","author":"Khelfi","year":"2016","journal-title":"Toxicol Anal Clin"},{"issue":"8","key":"10.1016\/j.pharma.2017.04.002_bib1170","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/acer.12771","article-title":"Alcohol differentially alters extracellular matrix and adhesion molecule expression in skeletal muscle and heart","volume":"39","author":"Steiner","year":"2015","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"10.1016\/j.pharma.2017.04.002_bib1175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2050-490X-1-2","article-title":"Chronic alcohol ingestion delays skeletal muscle regeneration following injury","volume":"1","author":"Dekeyser","year":"2013","journal-title":"Regen Med Res"},{"issue":"9","key":"10.1016\/j.pharma.2017.04.002_bib0590","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1096\/fj.14-254011","article-title":"Glucocorticoids increase adipocytes in muscle by affecting IL-4\u00a0regulated FAP activity","volume":"28","author":"Dong","year":"2014","journal-title":"Faseb J"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450917300305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450917300305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T23:33:03Z","timestamp":1757719983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450917300305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":118,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0003450917300305"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2017.04.002","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"M\u00e9canismes d\u2019action directs mis en jeu dans les myopathies toxiques","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2017.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}